League City, TX, United States of America

Jia Zhou

This inventor holds 37 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: The University of Texas System, Baker Hughes, a Ge Compnay, LLC, Baker Hughes Corporation. Active years: 2015-2025.

USPTO Granted Patents = 37 (Patent Applications = 15)

% Patents Active = 89.2

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 57(Granted Patents)

Location History:

The Woodlands, TX (US) (2017)
Spring, TX (US) (2016 - 2019)
Cypress, TX (US) (2017 - 2020)
Austin, TX (US) (2019 - 2021)
League City, TX (US) (2015 - 2023)
Galveston, TX (US) (2020 - 2024)

Company Filing History:

26 out of 5,622

The University of Texas System

patents

6 out of 1,389

Baker Hughes, a Ge Compnay, LLC

patents

4 out of 5,728

Baker Hughes Corporation

Health Research, Inc.

patents

7. 1 out of 1,045

The University of Arizona

patents

8. 1 out of 3,511

University of Michigan

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

GPR52 Agonists

BRD4 Inhibitors

Anti-Pain Medication

Cancer Therapy

HIV Modulators

Neuropsychiatric Disorders

Hydraulic Fracturing

Viral Replication

EPAC Antagonists

Fracturing Fluids

Superabsorbent Polymers

STAT3 Inhibitors

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441686 - Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists (2025-10-14),

2. 12291553 - Non-opioid anti-pain medication (2025-05-06),

3. 12077540 - Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues (2024-09-03),

4. 12043602 - Fendiline derivatives (2024-07-23),

5. 11773065 - Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists (2023-10-03),

6. 11767303 - Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections (2023-09-26),

7. 11407752 - Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2′,5(3H)-dione analogues (2022-08-09),

8. 11389433 - BRD4 inhibitor treatment of IgE-mediated diseases (2022-07-19),

9. 11124489 - EPAC antagonists (2021-09-21),

10. 11117865 - Inhibitors of bromodomain-containing protein 4 (BRD4) (2021-09-14),

11. 10975059 - Small molecule BRD4 modulators for HIV epigenetic regulation (2021-04-13),

12. 10889543 - Fine-tune modulators of neuronal excitability for neuropsychiatric disorders (2021-01-12),

13. 10633363 - EPAC1 activators as HIV latency reversal agents (LRA) (2020-04-28),

14. 10570700 - Fracturing fluids and methods of treating hydrocarbon formations (2020-02-25),

15. 10457662 - Substituted amides for treating and preventing cancer (2019-10-29),

Title: Innovations of Jia Zhou: A Look at His Patents and Contributions

Introduction

Jia Zhou, based in League City, Texas, is a prolific inventor with a remarkable record of 24 patents to his name. His innovative work primarily focuses on the development of novel compounds and derivatives that have significant potential in various applications.

Latest Patents

Among his latest contributions are groundbreaking patents, including a series of substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2′,5(3H)-dione analogues. This inventive work encompasses not only the compounds themselves but also their preparation and use. Additionally, he has developed novel fendiline derivatives, detailing specific formulations that highlight their potential applications.

Career Highlights

Jia Zhou has made significant strides in his career, notably working with prestigious institutions such as the University of Texas System and Emory University. His associations with these renowned organizations have allowed him to contribute to advanced research and innovation within the scientific community.

Collaborations

Throughout his career, Jia Zhou has collaborated with talented individuals, including colleagues like Chunyong Ding and Zhiqing Liu. These collaborations have been instrumental in facilitating the exchange of ideas and enhancing research productivity.

Conclusion

Jia Zhou's contributions to innovations and inventions, particularly in the realm of chemical compounds, showcase his dedication to advancing technology and science. His impressive portfolio of patents reflects not only his creativity but also his commitment to solving complex challenges through innovative solutions.